Answer:
Yes, this is still a Schedule I drug for DEA and we still file SARs as outlined in the 2014 Guidance. Some financial institutions only file SARS on Tier I high risk businesses that touch product and 100% of business is marijuana related. This needs to be spelled out in your procedures.
------------------------------------
Learn more about Deborah Crawford’s BSA/OFAC Officer Summer Update 2024 webinar.